![Shan Shan Di](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shan Shan Di
Direktor/Vorstandsmitglied bei ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Profil
Shan Shan Di is currently a Member-Supervisory Board at Asymchem Laboratories (Tianjin) Co., Ltd.
Prior to this, Ms. Di worked as a Deputy Director-Administration at Asymchem Life Science Tianjin Co. Ltd.
Ms. Di received a graduate degree from Sichuan University in 2012 and an undergraduate degree from Hebei University of Technology in 2009.
Aktive Positionen von Shan Shan Di
Unternehmen | Position | Beginn |
---|---|---|
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Direktor/Vorstandsmitglied | 31.10.2017 |
Ehemalige bekannte Positionen von Shan Shan Di
Unternehmen | Position | Ende |
---|---|---|
Asymchem Life Science Tianjin Co. Ltd.
![]() Asymchem Life Science Tianjin Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical raw materials. The company is based in Tianjin, China. Yi Xiao has been the CEO of the Chinese company since 2018. | Verwaltungsdirektor | - |
Ausbildung von Shan Shan Di
Hebei University of Technology | Undergraduate Degree |
Sichuan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Asymchem Life Science Tianjin Co. Ltd.
![]() Asymchem Life Science Tianjin Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical raw materials. The company is based in Tianjin, China. Yi Xiao has been the CEO of the Chinese company since 2018. | Health Technology |